1. Home
  2. LCUT vs GANX Comparison

LCUT vs GANX Comparison

Compare LCUT & GANX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LCUT
  • GANX
  • Stock Information
  • Founded
  • LCUT 1945
  • GANX 2017
  • Country
  • LCUT United States
  • GANX United States
  • Employees
  • LCUT N/A
  • GANX N/A
  • Industry
  • LCUT Industrial Machinery/Components
  • GANX Biotechnology: Pharmaceutical Preparations
  • Sector
  • LCUT Consumer Discretionary
  • GANX Health Care
  • Exchange
  • LCUT Nasdaq
  • GANX Nasdaq
  • Market Cap
  • LCUT 85.4M
  • GANX 79.8M
  • IPO Year
  • LCUT 1991
  • GANX 2021
  • Fundamental
  • Price
  • LCUT $3.43
  • GANX $1.87
  • Analyst Decision
  • LCUT Buy
  • GANX Strong Buy
  • Analyst Count
  • LCUT 2
  • GANX 6
  • Target Price
  • LCUT $5.50
  • GANX $8.00
  • AVG Volume (30 Days)
  • LCUT 22.0K
  • GANX 910.4K
  • Earning Date
  • LCUT 11-06-2025
  • GANX 11-13-2025
  • Dividend Yield
  • LCUT 4.94%
  • GANX N/A
  • EPS Growth
  • LCUT N/A
  • GANX N/A
  • EPS
  • LCUT N/A
  • GANX N/A
  • Revenue
  • LCUT $670,991,000.00
  • GANX N/A
  • Revenue This Year
  • LCUT N/A
  • GANX N/A
  • Revenue Next Year
  • LCUT $2.43
  • GANX N/A
  • P/E Ratio
  • LCUT N/A
  • GANX N/A
  • Revenue Growth
  • LCUT N/A
  • GANX N/A
  • 52 Week Low
  • LCUT $2.89
  • GANX $1.41
  • 52 Week High
  • LCUT $7.05
  • GANX $3.19
  • Technical
  • Relative Strength Index (RSI)
  • LCUT 38.26
  • GANX 48.11
  • Support Level
  • LCUT $3.41
  • GANX $1.80
  • Resistance Level
  • LCUT $3.69
  • GANX $2.09
  • Average True Range (ATR)
  • LCUT 0.15
  • GANX 0.20
  • MACD
  • LCUT -0.03
  • GANX -0.02
  • Stochastic Oscillator
  • LCUT 4.69
  • GANX 12.12

About LCUT Lifetime Brands Inc.

Lifetime Brands Inc is a U.S. based company that designs, sources, and sells branded kitchenware, tableware, and other products used in the home and markets its products under brands such as Farberware, KitchenAid, Mikasa, and others. The company markets and sells its products principally on a wholesale basis to retailers. It also markets and sells a limited selection of its products directly to consumers through its Pfaltzgraff, Mikasa, Fred, and Friends, Built NY, and others. Its products include kitchen tools, gadgets, cutlery, dinnerware, and glassware. The segments of the company are the U.S. and International. It derives a majority of its revenue from the U.S. segment. The company derives maximum revenue from Kitchenware products.

About GANX Gain Therapeutics Inc.

Gain Therapeutics Inc is a biotechnology company developing novel small molecule therapeutics to treat diseases across several therapeutic areas, including, lysosomal storage disorders, central nervous system disorders, metabolic disorders, and oncology. The company's clinical-stage product candidate, GT-02287, is being developed for the treatment of GBA1 Parkinson's disease. The company uses its computational target and drug discovery platform, Magellan, to discover novel allosteric binding sites on proteins implicated in disease and to identify proprietary small molecules that bind these sites to modulate protein function and treat the underlying cause of the disease. Geographically, the company operates in Switzerland, Spain, the United States, and Australia.

Share on Social Networks: